What’s new, what’s next and where to find us. This is your hub for our CRO lab announcements, insights and events—because in bioanalysis, momentum matters.
Veloxity Labs announced a remarkable 50% year-over-year growth in 2024. This milestone underscores our dedication to accelerating therapeutic development..
We’re thrilled to release our latest thought leadership report, Updates in Animal Health Bioanalysis: Transitioning to the ICH M10 Bioanalytical Guidance."
We’re excited to announce that Lucinda Hittle has joined our Board of Advisors! She brings over three decades of experience in the pharma and biotech sectors.
We’re thrilled to announce the addition of Tammy Herman to Veloxity! As the QA Auditor, Tammy will work to ensure compliance with GLP and GCP requirements.
Veloxity Labs has emerged as a force, blending innovation and expertise to redefine the possibilities of tech solutions. Read more in this article from The Silicon Review.
Since 2007, the Peoria NEXT Innovation Center has been hatching local startups, letting them leave the nest and soar. Read more in this article from Peoria Magazine.
At Pittcon 2026, Veloxity is proud to participate with a featured speaking session focused on leadership and team development. Reach out to discuss more.
Veloxity will be attending the ASCPT 2026 Annual Meeting to engage with teams navigating early clinical development, PK/TK strategy and regulated bioanalysis.
If GLP/ICH M10–aligned peptide bioanalysis (incl. GLP-1 RAs) or complex matrices are on your 2025–26 roadmap, let’s connect in Phoenix at the ACT 46th Annual Meeting.
Book a 15-minute meeting to learn more about our capabilities.
If peptide bioanalysis (incl. GLP-1 RAs) or complex matrices are on your 2025–26 roadmap, we’d love to compare notes at AAPS 2025 PharmSci 360.
Book a 15-minute meeting to learn more about our capabilities
